Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw

Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw

Introduction: One of the most common side effects of bisphosphonate intake is osteonecrosis of the jaw (ONJ) which may develop following dentoalveolar interventions. Despite the vast available protocols, there is no clear guideline in the management of this condition. In osteonecrosis, the number an...

Full description

Bibliographic Details
Main Authors: Pantea Nazeman, Maryam Rezai Rad, Arash Khojasteh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Dental Hypotheses
Subjects:
Bisphosphonate
erythropoietin
osteonecrosis of the jaw
Online Access:http://www.dentalhypotheses.com/article.asp?issn=2155-8213;year=2016;volume=7;issue=2;spage=56;epage=60;aulast=Nazeman

Similar Items

Similar Items